Literature DB >> 25673951

Cutaneous spindle cell squamous cell carcinoma.

Joo Hee Lee1, Young Bok Lee1, Jin Wou Kim1, Dong Soo Yu1.   

Abstract

Entities:  

Year:  2015        PMID: 25673951      PMCID: PMC4323593          DOI: 10.5021/ad.2015.27.1.113

Source DB:  PubMed          Journal:  Ann Dermatol        ISSN: 1013-9087            Impact factor:   1.444


× No keyword cloud information.
Dear Editor: Spindle cell squamous cell carcinoma (SpSCC) is a rare variant of squamous cell carcinoma (SCC). Despite having clinical attributes that overlap conventional SCC, these lesions are pathologically distinct and are comprised of spindled cells that infiltrate the dermis as single cells or cohesive nests; that lack features of keratinization. SpSCC most commonly occurs in the larynx, and less often in the hypopharynx, oropharynx, and nasal cavity1. It is extremely rare to find SpSCC confined to the cutaneous lesion, and only three cases have previously been reported in Korea. A 73-year-old woman presented with a 1-year history of a pruritic, solitary mass on the face. Physical examination revealed an irregular-shaped, erythematous, firm, fixed mass with a yellowish crust on her left upper perioral area. The mass was 1.3 cm in diameter and was slowly expanding (Fig. 1). The patient had a history of a wide excision of basal cell carcinoma on her nose 2 years previously, and no relapse has been observed.
Fig. 1

(A, B) Solitary, 1.3 cm-sized, irregular-shaped, erythematous, firm mass with a yellowish crust on the left upper perioral area.

Histologic examination of the lesion showed spindle-shaped cells with hyperchromatic nuclei infiltrating the dermis in a whorl-like pattern (Fig. 2). Furthermore, immunohistochemical investigation revealed the specimen was positive for cytokeratins (34βE12, CK5/6, AE1/3) and vimentin, but was negative for smooth muscle actin (SMA), S-100, and CD68. Through histologic features and immunohistochemical evaluation, she was diagnosed with SpSCC. The lesion was surgically removed 13 months previously and no relapse has been observed.
Fig. 2

(A) Diffuse dermal infiltrates of spindle cells (H&E, ×40). (B, C) Numerous spindle cells in a whorl-like pattern and atypical mitotic figures (H&E; B: ×200, C: ×400). (D) Positive immunostaining for 34βE12, (E) CK5/6, (F) AE1/3, and (G) vimentin (D~G: ×200). (H) Negative immunostaining for smooth muscle actin, (I) S-100, and (J) CD68 (H~J: ×400).

Cutaneous SpSCC presents as a raised or exophytic nodule accompanied by spontaneous bleeding and central ulceration similar to conventional SCC2. It is usually confined to sun-damaged sites such as the head, neck, chest, and upper extremities or areas that have received prior ionizing radiation2,3. Although the rarity of these tumors makes difficult to study patient survival rates, the literature suggests an overall prognosis similar to that of conventional SCC. SpSCC must be distinguished from other spindle cell lesions such as atypical fibroxanthoma (AFX), spindle cell/desmoplastic melanoma, cutaneous leiomyosarcoma, and scars. Immunohistochemistry has become the essential method in the pathologic workup of these tumors. The spindle cells in SpSCC stained positively for one or more of the cytokeratins (34βE12, AE1/3, cam 5.2, low molecular weight keratin) and the mesenchymal marker, vimentin. Each of these neoplasms stained negatively for S-100, CD68, and SMA; whereas AFX showed positivity for CD68, but lacked keratin and S-100. The spindle cell melanomas showed a connection with the epithelium that was contiguous with similar junctional cells possessing cytoplasmic melanin and S-100 immunostaining, but lacking keratins. The leiomyosarcomas showed positivity with SMA and vimentin, and were negative for keratins and S-100. The scars were negative for all immunohistochemical stains4. Cutaneous SpSCC is so rare subtype of SCC that pathophysiology, prognostic factors, and metastatic risk are not well-established. It is known that SpSCCs that are associated with radiation, burn scars, and immunosuppression may correlate with aggressive clinical courses5. Further studies of this rare entity are needed to establish its biological behavior, and the accumulation of more case reports will aid in determining a precise prognosis.
  4 in total

1.  Spindle cell carcinoma of the larynx: review of 26 cases including DNA content and immunohistochemistry.

Authors:  J E Lewis; K D Olsen; T J Sebo
Journal:  Hum Pathol       Date:  1997-06       Impact factor: 3.466

2.  Immunohistochemical distinction of cutaneous spindle cell carcinoma.

Authors:  Michael B Morgan; Chetna Purohit; Tiffany R Anglin
Journal:  Am J Dermatopathol       Date:  2008-06       Impact factor: 1.533

Review 3.  Cutaneous squamous cell carcinoma: a comprehensive clinicopathologic classification. Part one.

Authors:  David S Cassarino; Damian P Derienzo; Ronald J Barr
Journal:  J Cutan Pathol       Date:  2006-03       Impact factor: 1.587

4.  Unusual spindle cell squamous carcinoma in a renal transplant patient.

Authors:  Hjalmar Kurzen; Martin Zeier; Bernhard Zelger; Wolfgang Hartschuh
Journal:  Acta Derm Venereol       Date:  2004       Impact factor: 4.437

  4 in total
  4 in total

1.  Prolonged Response to Pembrolizumab in Spindle Cell Squamous Cell Carcinoma Metastatic to the Central Nervous System.

Authors:  Yuxin Liu; Bailey Fitzgerald; Edward Perry; Ashutosh Pathak; Herta H Chao
Journal:  J Investig Med High Impact Case Rep       Date:  2019 Jan-Dec

2.  Multifocal Superficial Rapidly Growing Postirradiation Sarcoma Mimicking Metastatic Carcinoma.

Authors:  Debasis Gochhait; Priyadarshini Dehuri; Vidhyalakshmi Rangarajan; Neelaiah Siddaraju
Journal:  J Midlife Health       Date:  2019 Apr-Jun

3.  A spindle cell squamous cell carcinoma on the cheek presenting with in-transit metastases and a satellite lesion.

Authors:  Eui-Tae Lee
Journal:  Arch Craniofac Surg       Date:  2020-02-20

4.  An Unexpected Transformation: Malignant Spindle Cell Carcinoma Developed From Primary Basal Cell Carcinoma.

Authors:  Erinie Mekheal; Sindhusha Veeraballi; Brooke E Kania; Leena Bondili; Michael Maroules
Journal:  Cureus       Date:  2022-07-07
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.